Trials / Active Not Recruiting
Active Not RecruitingNCT04624698
iStent Inject New Enrollment Post-Approval Study
iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 358 (estimated)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
Study to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.
Detailed description
To evaluate the rate of clinically relevant complications associated with iStent inject placement and stability, as determined at 36 months in the postmarket setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | iStent Inject Implantation | Subjects will be implanted with the iStent Injection Micro-Bypass device |
Timeline
- Start date
- 2020-09-22
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2020-11-12
- Last updated
- 2024-02-23
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04624698. Inclusion in this directory is not an endorsement.